During a Case-Based Roundtable® event, Neeraj Agarwal, MD, and participants discussed how they might determine which ...

Metabolic dysregulation in the development of clear cell renal cell carcinoma (ccRCC) remains to be understood. Here the authors identify that a carnitine synthesis enzyme BBOX1, which inhibits ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma. February 7, 2025 New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...

Clinical Department of Dermatology, Regional Hospital, Opole, Poland Department of Oncology, Institute of Medical Sciences, University of Opole, Opole, Poland Prof. Tadeusz Koszarowski Opole Oncology ...

Treatment for renal cell carcinoma can vary depending on the size of your tumor, your overall health, how advanced your cancer is, and other factors. Some of the options include surgery, radiation ...

Scientists have revealed the secret to the structural integrity of tiny particles that transport cargo from cell to cell through ... and cardiovascular disease, cancer and neurological disorders.

Non-Hodgkin lymphoma (NHL) is generally divided into 2 main types, based on whether it starts in B lymphocytes (B cells) or T lymphocytes (T cells). There are many different types of B-cell lymphomas.